Quarterly report · Q2

Period2022-04-01 → 2022-09-30
Filed2022-11-10
StandardJapan GAAP
ConsolidatedYes
Data checks14 of 14 passed
Key figures · 46
MetricValuePeriodScopeSource row
Revenue¥47.0bn2022-04-01 → 2022-09-30Cons.Net sales
Revenue¥84.1bn2021-04-01 → 2022-03-31Cons.Net sales (5-year summary)
Revenue¥41.1bn2021-04-01 → 2021-09-30Cons.Net sales
Operating income¥4.6bn2022-04-01 → 2022-09-30Cons.Operating income
Operating income¥3.9bn2021-04-01 → 2021-09-30Cons.Operating income
Ordinary income¥6.2bn2022-04-01 → 2022-09-30Cons.Ordinary income
Ordinary income¥8.1bn2021-04-01 → 2022-03-31Cons.Ordinary income loss (5-year summary)
Ordinary income¥3.9bn2021-04-01 → 2021-09-30Cons.Ordinary income
Profit before tax¥9.9bn2022-04-01 → 2022-09-30Cons.Income before income taxes
Profit before tax¥3.5bn2021-04-01 → 2021-09-30Cons.Income before income taxes
Net income (owners)¥7.5bn2022-04-01 → 2022-09-30Cons.Profit loss attributable to owners of parent
Net income (owners)¥6.5bn2021-04-01 → 2022-03-31Cons.Profit loss attributable to owners of parent (5-year summary)
Net income (owners)¥2.3bn2021-04-01 → 2021-09-30Cons.Profit loss attributable to owners of parent
Net income¥7.6bn2022-04-01 → 2022-09-30Cons.Profit loss
Net income¥2.4bn2021-04-01 → 2021-09-30Cons.Profit loss
Total assets¥198.6bnat 2022-09-30Cons.Assets
Total assets¥187.3bnat 2022-03-31Cons.Assets
Total assets¥184.1bnat 2021-09-30Cons.Total assets (5-year summary)
Total liabilities¥80.6bnat 2022-09-30Cons.Liabilities
Total liabilities¥76.7bnat 2022-03-31Cons.Liabilities
Net assets / equity¥118.0bnat 2022-09-30Cons.Net assets
Net assets / equity¥110.6bnat 2022-03-31Cons.Net assets
Net assets / equity¥107.5bnat 2021-09-30Cons.Net assets (5-year summary)
Cash and deposits¥25.5bnat 2022-09-30Cons.Cash and deposits
Cash and deposits¥18.5bnat 2022-03-31Cons.Cash and deposits
Cash & equivalents¥25.4bnat 2022-09-30Cons.Cash and cash equivalents
Cash & equivalents¥18.5bnat 2022-03-31Cons.Cash and cash equivalents
Cash & equivalents¥22.2bnat 2021-09-30Cons.Cash and cash equivalents
Cash & equivalents¥30.2bnat 2021-03-31dCons.Cash and cash equivalents
Operating cash flow¥6.3bn2022-04-01 → 2022-09-30Cons.Net cash provided by used in operating activities
Operating cash flow¥7.0bn2021-04-01 → 2022-03-31Cons.Net cash provided by used in operating activities (5-year summary)
Operating cash flow¥3.5bn2021-04-01 → 2021-09-30Cons.Net cash provided by used in operating activities
Investing cash flow¥1.0bn2022-04-01 → 2022-09-30Cons.Net cash provided by used in investment activities
Investing cash flow−¥17.3bn2021-04-01 → 2022-03-31Cons.Net cash provided by used in investing activities (5-year summary)
Investing cash flow−¥10.0bn2021-04-01 → 2021-09-30Cons.Net cash provided by used in investment activities
Financing cash flow−¥1.5bn2022-04-01 → 2022-09-30Cons.Net cash provided by used in financing activities
Financing cash flow−¥1.5bn2021-04-01 → 2022-03-31Cons.Net cash provided by used in financing activities (5-year summary)
Financing cash flow−¥1.7bn2021-04-01 → 2021-09-30Cons.Net cash provided by used in financing activities
EPS (basic)¥195.322022-04-01 → 2022-09-30Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥70.82022-07-01 → 2022-09-30dCons.Basic earnings loss per share (5-year summary)
EPS (basic)¥168.042021-04-01 → 2022-03-31Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥60.372021-04-01 → 2021-09-30Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥39.342021-07-01 → 2021-09-30dCons.Basic earnings loss per share (5-year summary)
Equity ratio56.7%at 2022-09-30Cons.Equity to asset ratio (5-year summary)
Equity ratio56.5%at 2022-03-31Cons.Equity to asset ratio (5-year summary)
Equity ratio55.4%at 2021-09-30Cons.Equity to asset ratio (5-year summary)

Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.

Segments · 70
SegmentItemPeriodValue
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentsrevenue2022-04-01 → 2022-09-30¥1.2bn
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentsrevenue external2022-04-01 → 2022-09-30¥530m
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentsrevenue intersegment2022-04-01 → 2022-09-30¥647m
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentssegment profit2022-04-01 → 2022-09-30¥59m
Reconciling Itemsreconcilingrevenue2022-04-01 → 2022-09-30−¥7.3bn
Reconciling Itemsreconcilingrevenue intersegment2022-04-01 → 2022-09-30−¥7.3bn
Reconciling Itemsreconcilingsegment profit2022-04-01 → 2022-09-30−¥159m
jpcrp040300-q2r_E00542-000Facility Materialsreportable segmentrevenue2022-04-01 → 2022-09-30¥10.1bn
jpcrp040300-q2r_E00542-000Facility Materialsreportable segmentrevenue external2022-04-01 → 2022-09-30¥9.8bn
jpcrp040300-q2r_E00542-000Facility Materialsreportable segmentrevenue intersegment2022-04-01 → 2022-09-30¥259m
jpcrp040300-q2r_E00542-000Facility Materialsreportable segmentsegment profit2022-04-01 → 2022-09-30¥90m
jpcrp040300-q2r_E00542-000Fiberreportable segmentrevenue2022-04-01 → 2022-09-30¥1.2bn
jpcrp040300-q2r_E00542-000Fiberreportable segmentrevenue external2022-04-01 → 2022-09-30¥1.2bn
jpcrp040300-q2r_E00542-000Fiberreportable segmentrevenue intersegment2022-04-01 → 2022-09-30¥0
jpcrp040300-q2r_E00542-000Fiberreportable segmentsegment profit2022-04-01 → 2022-09-30¥65m
jpcrp040300-q2r_E00542-000Functional Materialsreportable segmentrevenue2022-04-01 → 2022-09-30¥13.8bn
jpcrp040300-q2r_E00542-000Functional Materialsreportable segmentrevenue external2022-04-01 → 2022-09-30¥13.5bn
jpcrp040300-q2r_E00542-000Functional Materialsreportable segmentrevenue intersegment2022-04-01 → 2022-09-30¥276m
jpcrp040300-q2r_E00542-000Functional Materialsreportable segmentsegment profit2022-04-01 → 2022-09-30¥2.7bn
jpcrp040300-q2r_E00542-000Interfibrillarreportable segmentrevenue2022-04-01 → 2022-09-30¥18.8bn
jpcrp040300-q2r_E00542-000Interfibrillarreportable segmentrevenue external2022-04-01 → 2022-09-30¥12.9bn
jpcrp040300-q2r_E00542-000Interfibrillarreportable segmentrevenue intersegment2022-04-01 → 2022-09-30¥5.8bn
jpcrp040300-q2r_E00542-000Interfibrillarreportable segmentsegment profit2022-04-01 → 2022-09-30¥368m
jpcrp040300-q2r_E00542-000Life Sciensereportable segmentrevenue2022-04-01 → 2022-09-30¥9.3bn
jpcrp040300-q2r_E00542-000Life Sciensereportable segmentrevenue external2022-04-01 → 2022-09-30¥9.1bn
jpcrp040300-q2r_E00542-000Life Sciensereportable segmentrevenue intersegment2022-04-01 → 2022-09-30¥233m
jpcrp040300-q2r_E00542-000Life Sciensereportable segmentsegment profit2022-04-01 → 2022-09-30¥1.5bn
—segment totalrevenue2022-04-01 → 2022-09-30¥53.1bn
—segment totalrevenue external2022-04-01 → 2022-09-30¥46.5bn
—segment totalrevenue intersegment2022-04-01 → 2022-09-30¥6.6bn
—segment totalsegment profit2022-04-01 → 2022-09-30¥4.7bn
Total Of Reportable Segments And Otherssegment totalrevenue2022-04-01 → 2022-09-30¥54.3bn
Total Of Reportable Segments And Otherssegment totalrevenue external2022-04-01 → 2022-09-30¥47.0bn
Total Of Reportable Segments And Otherssegment totalrevenue intersegment2022-04-01 → 2022-09-30¥7.3bn
Total Of Reportable Segments And Otherssegment totalsegment profit2022-04-01 → 2022-09-30¥4.8bn
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentsrevenue2021-04-01 → 2021-09-30¥2.3bn
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentsrevenue external2021-04-01 → 2021-09-30¥427m
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentsrevenue intersegment2021-04-01 → 2021-09-30¥1.9bn
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentssegment profit2021-04-01 → 2021-09-30¥258m
Reconciling Itemsreconcilingrevenue2021-04-01 → 2021-09-30−¥7.7bn
Reconciling Itemsreconcilingrevenue intersegment2021-04-01 → 2021-09-30−¥7.7bn
Reconciling Itemsreconcilingsegment profit2021-04-01 → 2021-09-30−¥389m
jpcrp040300-q2r_E00542-000Facility Materialsreportable segmentrevenue2021-04-01 → 2021-09-30¥9.0bn
jpcrp040300-q2r_E00542-000Facility Materialsreportable segmentrevenue external2021-04-01 → 2021-09-30¥8.8bn
jpcrp040300-q2r_E00542-000Facility Materialsreportable segmentrevenue intersegment2021-04-01 → 2021-09-30¥262m
jpcrp040300-q2r_E00542-000Facility Materialsreportable segmentsegment profit2021-04-01 → 2021-09-30¥80m
jpcrp040300-q2r_E00542-000Fiberreportable segmentrevenue2021-04-01 → 2021-09-30¥1.3bn
jpcrp040300-q2r_E00542-000Fiberreportable segmentrevenue external2021-04-01 → 2021-09-30¥1.3bn
jpcrp040300-q2r_E00542-000Fiberreportable segmentrevenue intersegment2021-04-01 → 2021-09-30¥8m
jpcrp040300-q2r_E00542-000Fiberreportable segmentsegment profit2021-04-01 → 2021-09-30−¥47m
jpcrp040300-q2r_E00542-000Functional Materialsreportable segmentrevenue2021-04-01 → 2021-09-30¥11.3bn
jpcrp040300-q2r_E00542-000Functional Materialsreportable segmentrevenue external2021-04-01 → 2021-09-30¥11.1bn
jpcrp040300-q2r_E00542-000Functional Materialsreportable segmentrevenue intersegment2021-04-01 → 2021-09-30¥184m
jpcrp040300-q2r_E00542-000Functional Materialsreportable segmentsegment profit2021-04-01 → 2021-09-30¥1.4bn
jpcrp040300-q2r_E00542-000Interfibrillarreportable segmentrevenue2021-04-01 → 2021-09-30¥16.4bn
jpcrp040300-q2r_E00542-000Interfibrillarreportable segmentrevenue external2021-04-01 → 2021-09-30¥11.2bn
jpcrp040300-q2r_E00542-000Interfibrillarreportable segmentrevenue intersegment2021-04-01 → 2021-09-30¥5.2bn
jpcrp040300-q2r_E00542-000Interfibrillarreportable segmentsegment profit2021-04-01 → 2021-09-30¥1.2bn
jpcrp040300-q2r_E00542-000Life Sciensereportable segmentrevenue2021-04-01 → 2021-09-30¥8.6bn
jpcrp040300-q2r_E00542-000Life Sciensereportable segmentrevenue external2021-04-01 → 2021-09-30¥8.3bn
jpcrp040300-q2r_E00542-000Life Sciensereportable segmentrevenue intersegment2021-04-01 → 2021-09-30¥248m
jpcrp040300-q2r_E00542-000Life Sciensereportable segmentsegment profit2021-04-01 → 2021-09-30¥1.4bn
—segment totalrevenue2021-04-01 → 2021-09-30¥46.5bn
—segment totalrevenue external2021-04-01 → 2021-09-30¥40.7bn
—segment totalrevenue intersegment2021-04-01 → 2021-09-30¥5.9bn
—segment totalsegment profit2021-04-01 → 2021-09-30¥4.1bn
Total Of Reportable Segments And Otherssegment totalrevenue2021-04-01 → 2021-09-30¥48.8bn
Total Of Reportable Segments And Otherssegment totalrevenue external2021-04-01 → 2021-09-30¥41.1bn
Total Of Reportable Segments And Otherssegment totalrevenue intersegment2021-04-01 → 2021-09-30¥7.7bn
Total Of Reportable Segments And Otherssegment totalsegment profit2021-04-01 → 2021-09-30¥4.3bn

Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.

All source rows · 555
ItemContextValueUnit
Notes revenue recognition quarterly consolidated financial statements (text)CurrentYTDDurationText · Plus
Notes per share information quarterly consolidated financial statements (text)CurrentYTDDurationText · Plus
Notes significant events after reporting period quarterly consolidated financial statements (text)CurrentYTDDurationText · Plus
Other information consolidated financial statements etc (text)CurrentYTDDurationText · Plus
Information about company which provides guarantee to reporting company (text)FilingDateInstantText · Plus

Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.

Data checks · 14 of 14 passed
balance sheet identityconsolidated 2022-03-31pass
balance sheet identityconsolidated 2022-09-30pass rounding
dei present pass
period resolution pass
statement vs summary · net assetsconsolidated 2022-03-31pass
statement vs summary · net assetsconsolidated 2022-09-30pass
statement vs summary · net income attributable to parentconsolidated 2021-04-01/2021-09-30pass
statement vs summary · net income attributable to parentconsolidated 2022-04-01/2022-09-30pass
statement vs summary · operating cash flowconsolidated 2021-04-01/2021-09-30pass
statement vs summary · operating cash flowconsolidated 2022-04-01/2022-09-30pass
statement vs summary · revenueconsolidated 2021-04-01/2021-09-30pass
statement vs summary · revenueconsolidated 2022-04-01/2022-09-30pass
statement vs summary · total assetsconsolidated 2022-03-31pass
statement vs summary · total assetsconsolidated 2022-09-30pass